期刊
FUNDAMENTAL & CLINICAL PHARMACOLOGY
卷 35, 期 2, 页码 379-388出版社
WILEY
DOI: 10.1111/fcp.12597
关键词
fatty liver; fenofibrate; IR; PPAR alpha; oxidative stress
The study evaluated the protective effects of fenofibrate on liver function, oxidant-antioxidant balance, and insulin resistance in rats fed high-fat-high-fructose diet. Results showed that fenofibrate can prevent fatty liver, improve glycemic status, reduce oxidative stress, and enhance antioxidant status in the rats. This suggests that fenofibrate has a role in lipid metabolism and diabetes prevention.
The present study evaluated the protective effects of fenofibrate on liver function, oxidant-antioxidant balance, and insulin resistance (IR) in rats fed high-fat-high-fructose diet (HFFD). Twenty-four male Sprague-Dawley rats (110-130 gm) were allocated into four equal groups (n = 6). Rats in group I were fed a normal diet for 4 weeks. Rats in group II were fed a normal diet with fenofibrate at 50 mg/kg/day orally for four weeks. Rats in group III were fed a normal diet mixed with 25% palm oil and given 60% fructose solution orally for 4 weeks. Rats in group IV were fed a normal diet mixed with 25% palm oil, 60% oral fructose solution, and fenofibrate at 50 mg/kg/day orally for four weeks. After experimental induction, serum and liver tissue samples were collected to determine lipid profiles, glycemic status, antioxidant status, oxidative and stress markers, and histopathology of liver tissues. The results of the present study revealed that fenofibrate prevents the occurrence of fatty liver, enhancing glycemic status, decreasing oxidative stress, and improving antioxidant status. It can be concluded that fenofibrate has a lipotropic and antidiabetic role.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据